✦ LIBER ✦

B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis

✍ Scribed by Jacob M van Laar

Book ID: 120705691
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 125 KB
Volume: 12
Category: Article
ISSN: 1478-6354
DOI: 10.1186/ar2977

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B cell depletion with rituximab in patie

B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis

✍ Robert Lafyatis; Eugene Kissin; Michael York; Giuseppina Farina; Kerry Viger; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

B cell block: is rituximab a new possibl

B cell block: is rituximab a new possible treatment for systemic sclerosis?

✍ Andrew Leask 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 67 KB

Successful rituximab-CHOP treatment of s

Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma

✍ Zs. Simon; T. Tarr; Zs. Ress; L. Gergely; E. Kiss; A. Illes 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

B cell depletion as a novel treatment fo

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab

✍ R. John Looney; Jennifer H. Anolik; Debbie Campbell; Raymond E. Felgar; Faith Yo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract ## Objective Safer and more effective therapies are needed for the treatment of systemic lupus erythematosus (SLE). B lymphocytes have been shown to play fundamental pathogenic roles in SLE, and therefore, elimination of B cells with the use of rituximab may represent a new therapy for

Acquired B cell immunophenotype of folli

Acquired B cell immunophenotype of follicular dendritic cells in a B cell-depleted lymph node after treatment with rituximab

✍ Blieden, Clifford; Medeiros, L. Jeffrey; Vega, Francisco 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 755 KB

Cost-Effectiveness Analysis of Rituximab

Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma

✍ Jennie H. Best; John Hornberger; Stephen J. Proctor; Louis F. Omnes; Fred Jost 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB